{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:09:21Z","timestamp":1790975361255,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaoning Provincial Science and Technology Joint Program","award":["2025-BSLH-390"],"award-info":[{"award-number":["2025-BSLH-390"]}]},{"name":"Liaoning Provincial Science and Technology Joint Program","award":["2024-MSLH-558"],"award-info":[{"award-number":["2024-MSLH-558"]}]},{"name":"Liaoning Provincial Science and Technology Joint Program","award":["2025-MSLH-737"],"award-info":[{"award-number":["2025-MSLH-737"]}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"crossref","award":["2023-MS-156"],"award-info":[{"award-number":["2023-MS-156"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Research Project of Liaoning Provincial Department of Education","award":["LJKMZ20221175"],"award-info":[{"award-number":["LJKMZ20221175"]}]},{"name":"Natural Science Foundation of liaoning Proveince","award":["2025-BS-0947"],"award-info":[{"award-number":["2025-BS-0947"]}]},{"name":"The Natural Science\u00a0Foundation of Liaoning Province","award":["2024-MS-054"],"award-info":[{"award-number":["2024-MS-054"]}]},{"name":"The Basic Scientific Research Project Plan for Higher Education Institutions of the Liaoning Provincial Department of Education","award":["LJ242410159046"],"award-info":[{"award-number":["LJ242410159046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Papillary thyroid carcinoma (PTC) undergoes dedifferentiation into aggressive poorly differentiated (PDTC) or anaplastic (ATC) carcinomas in 10\u201315% of cases, a process potentially driven by cancer-associated fibroblasts (CAFs) within the tumor microenvironment (TME), though their spatiotemporal dynamics remain poorly understood. Resveratrol (Res), a natural compound, has shown anticancer potential by promoting redifferentiation and apoptosis while inhibiting oncogenic signaling, suggesting utility in countering PTC dedifferentiation. Using spatial transcriptomics (10\u00d7 Visium) on three surgical specimens, we obtained 14,191 high-quality spots annotated via UMAP and Leiden clustering into seven cell types, including CAFs, T cells, B cells, and others. Comparative gene expression and functional enrichment analyses revealed CAFs in poorly differentiated regions exhibited heightened glycolytic activity, correlated with ZFP57 upregulation and PKM2 induction. Glycolysis was validated through immunofluorescence, Seahorse assays, glucose\/lactate measurements, and ZFP57-PKM2 reporter assays. CAF-conditioned media promoted PTC proliferation, invasion, and dedifferentiation while reducing radioiodine uptake in co-culture models. In xenografts, ZFP57 overexpression increased tumor growth and impaired radioiodine retention, whereas Res suppressed ZFP57, restored differentiation, enhanced radioiodine avidity, and inhibited glycolysis. Mechanistically, CAF-secretated lactate activated TGF-\u03b2\/Smad2\/3 signaling, fostering dedifferentiation and malignancy. Resveratrol reversed these effects by targeting ZFP57, normalizing CAF metabolism, and restoring PTC differentiation, indicating a promising therapeutic strategy against PTC progression.<\/jats:p>","DOI":"10.1186\/s13046-026-03675-w","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:34:11Z","timestamp":1772170451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanism of cancer-associated fibroblast-driven thyroid cancer dedifferentiation via the ZFP57-PKM2 axis-mediated lactate secretion and therapeutic intervention with resveratrol\u200b"],"prefix":"10.1186","volume":"45","author":[{"given":"Xiaoyu","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"3675_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/thy.2010.0021","volume":"21","author":"B Aschebrook-Kilfoy","year":"2011","unstructured":"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992\u20132006. Thyroid. 2011;21:125\u201334.","journal-title":"Thyroid"},{"key":"3675_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1\u2013133.","journal-title":"Thyroid"},{"key":"3675_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ. Papillary and follicular thyroid carcinoma. New Engl J Med. 1998;338:297\u2013306.","journal-title":"New Engl J Med"},{"key":"3675_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"3675_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783\u201395.","journal-title":"Lancet"},{"key":"3675_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644\u201360.","journal-title":"Nat Rev Endocrinol"},{"key":"3675_CR7","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es-Pereira J, Capit\u00e3o R, Limbert E, Leite V. Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options. Cancers. 2019;11:1188.","DOI":"10.3390\/cancers11081188"},{"key":"3675_CR8","doi-asserted-by":"crossref","unstructured":"Ma B, Xu W, Wei W, Wen D, Lu Z, Yang S et al. Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC. Int J Endocrinol. 2018; 2018: 2383715.","DOI":"10.1155\/2018\/2383715"},{"key":"3675_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi S, de Sauvage FJ. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat Rev Drug Discov. 2020;19:39\u201356.","journal-title":"Nat Rev Drug Discov"},{"key":"3675_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2018.08.009","volume":"53","author":"SV Da","year":"2018","unstructured":"Da SV, Lorenzo-Sanz L, Bernat-Peguera A, Lopez-Cerda M, Mu\u00f1oz P. Cancer cell plasticity: Impact on tumor progression and therapy response. Semin Cancer Biol. 2018;53:48\u201358.","journal-title":"Semin Cancer Biol"},{"key":"3675_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501:328\u201337.","journal-title":"Nature"},{"key":"3675_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126:1052\u201366.","journal-title":"J Clin Invest"},{"key":"3675_CR13","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/s41467-019-10680-5","volume":"10","author":"SK Yoo","year":"2019","unstructured":"Yoo SK, Song YS, Lee EK, Hwang J, Kim HH, Jung G, et al. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat Commun. 2019;10:2764.","journal-title":"Nat Commun"},{"key":"3675_CR14","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/clinem\/dgab014","volume":"106","author":"L Zhang","year":"2021","unstructured":"Zhang L, Ren Z, Su Z, Liu Y, Yang T, Cao M, et al. Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer. J Clin Endocr Metab. 2021;106:988\u201398.","journal-title":"J Clin Endocr Metab"},{"key":"3675_CR15","doi-asserted-by":"publisher","first-page":"E1600","DOI":"10.1073\/pnas.1404357111","volume":"111","author":"DG McFadden","year":"2014","unstructured":"McFadden DG, Vernon A, Santiago PM, Martinez-McFaline R, Bhutkar A, Crowley DM, et al. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer. P Natl Acad Sci Usa. 2014;111:E1600\u20139.","journal-title":"P Natl Acad Sci Usa"},{"key":"3675_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501\u201311.","journal-title":"Lancet"},{"key":"3675_CR17","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.7150\/thno.26546","volume":"8","author":"Q Sun","year":"2018","unstructured":"Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, et al. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics. 2018;8:5072\u201387.","journal-title":"Theranostics"},{"key":"3675_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"3675_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastro Hepat. 2019;16:282\u201395.","journal-title":"Nat Rev Gastro Hepat"},{"key":"3675_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020;30:507\u201319.","journal-title":"Cell Res"},{"key":"3675_CR21","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1084\/jem.20180818","volume":"215","author":"Y Raz","year":"2018","unstructured":"Raz Y, Cohen N, Shani O, Bell RE, Novitskiy SV, Abramovitz L, et al. Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer. J Exp Med. 2018;215:3075\u201393.","journal-title":"J Exp Med"},{"key":"3675_CR22","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1007\/s00018-017-2646-2","volume":"74","author":"D Cui","year":"2017","unstructured":"Cui D, Huang Z, Liu Y, Ouyang G. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression. Cell Mol Life Sci. 2017;74:4287\u201391.","journal-title":"Cell Mol Life Sci"},{"key":"3675_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/1878-0261.12837","volume":"15","author":"WF Wei","year":"2021","unstructured":"Wei WF, Chen XJ, Liang LJ, Yu L, Wu XG, Zhou CF, et al. Periostin(+) cancer-associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma. Mol Oncol. 2021;15:210\u201327.","journal-title":"Mol Oncol"},{"key":"3675_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"I Malanchi","year":"2011","unstructured":"Malanchi I, Santamaria-Mart\u00ednez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481:85\u20139.","journal-title":"Nature"},{"key":"3675_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41419-018-1116-6","volume":"9","author":"B Yu","year":"2018","unstructured":"Yu B, Wu K, Wang X, Zhang J, Wang L, Jiang Y, et al. Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. Cell Death Dis. 2018;9:1082.","journal-title":"Cell Death Dis"},{"key":"3675_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-024-02040-9","volume":"23","author":"Y Jin","year":"2024","unstructured":"Jin Y, Zuo Y, Li G, Liu W, Pan Y, Fan T, et al. Advances in spatial transcriptomics and its applications in cancer research. Mol Cancer. 2024;23:129.","journal-title":"Mol Cancer"},{"key":"3675_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","volume":"41","author":"L Tian","year":"2023","unstructured":"Tian L, Chen F, Macosko EZ. The expanding vistas of spatial transcriptomics. Nat Biotechnol. 2023;41:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"3675_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-3-030-91836-1_16","volume":"1361","author":"O Van Oekelen","year":"2022","unstructured":"Van Oekelen O, Lagan\u00e0 A. Multi-Omics Profiling of the Tumor Microenvironment. Adv Exp Med Biol. 2022;1361:283\u2013326.","journal-title":"Adv Exp Med Biol"},{"key":"3675_CR29","doi-asserted-by":"publisher","first-page":"104281","DOI":"10.1016\/j.ebiom.2022.104281","volume":"84","author":"W Guo","year":"2022","unstructured":"Guo W, Zhou B, Yang Z, Liu X, Huai Q, Guo L, et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. Ebiomedicine. 2022;84:104281.","journal-title":"Ebiomedicine"},{"key":"3675_CR30","doi-asserted-by":"publisher","first-page":"112356","DOI":"10.1016\/j.ejmech.2020.112356","volume":"200","author":"R Ahmadi","year":"2020","unstructured":"Ahmadi R, Ebrahimzadeh MA. Resveratrol - A comprehensive review of recent advances in anticancer drug design and development. Eur J Med Chem. 2020;200:112356.","journal-title":"Eur J Med Chem"},{"key":"3675_CR31","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1002\/ptr.7562","volume":"36","author":"N Mohammadipoor","year":"2022","unstructured":"Mohammadipoor N, Shafiee F, Rostami A, Kahrizi MS, Soleimanpour H, Ghodsi M, et al. Resveratrol supplementation efficiently improves endothelial health: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36:3529\u201339.","journal-title":"Phytother Res"},{"key":"3675_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, et al. Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Lett. 2021;515:63\u201372.","journal-title":"Cancer Lett"},{"key":"3675_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2003.07.002","volume":"351","author":"Q Wang","year":"2003","unstructured":"Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu J. Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett. 2003;351:83\u20136.","journal-title":"Neurosci Lett"},{"key":"3675_CR34","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/cddiscovery.2015.71","volume":"2","author":"LX Zhong","year":"2016","unstructured":"Zhong LX, Zhang Y, Wu ML, Liu YN, Zhang P, Chen XY, et al. Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells. Cell Death Discov. 2016;2:15071.","journal-title":"Cell Death Discov"},{"key":"3675_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.200900437","volume":"54","author":"CH Cottart","year":"2010","unstructured":"Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54:7\u201316.","journal-title":"Mol Nutr Food Res"},{"key":"3675_CR36","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","volume":"58","author":"A Rauf","year":"2018","unstructured":"Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS. Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci. 2018;58:1428\u201347.","journal-title":"Crit Rev Food Sci"},{"key":"3675_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/thy.2009.0171","volume":"20","author":"H Sebai","year":"2010","unstructured":"Sebai H, Hovs\u00e9pian S, Ristorcelli E, Aouani E, Lombardo D, Fayet G. Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5. Thyroid. 2010;20:195\u2013203.","journal-title":"Thyroid"},{"key":"3675_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-023-10159-2","volume":"43","author":"US Shenoy","year":"2024","unstructured":"Shenoy US, Adiga D, Alhedyan F, Kabekkodu SP, Radhakrishnan R. HOXA9 transcription factor is a double-edged sword: from development to cancer progression. Cancer Metast Rev. 2024;43:709\u201328.","journal-title":"Cancer Metast Rev"},{"key":"3675_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41419-019-1335-5","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Wu X, Xie H, Yao N, Xia Y, Ma G, et al. ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt\/\u03b2-catenin signalling pathway. Cell Death Dis. 2019;10:169.","journal-title":"Cell Death Dis"},{"key":"3675_CR40","first-page":"172","volume":"15","author":"V Miranda-Gon\u00e7alves","year":"2013","unstructured":"Miranda-Gon\u00e7alves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, et al. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neurooncology. 2013;15:172\u201388.","journal-title":"Neurooncology"},{"key":"3675_CR41","doi-asserted-by":"publisher","first-page":"e2406870","DOI":"10.1002\/smll.202406870","volume":"21","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li H, Hao YY, Huang LL, Li X, Zou J, et al. Tumor-Selective Nano-Dispatcher Enforced Cancer Immunotherapeutic Effects via Regulating Lactate Metabolism and Activating Toll-Like Receptors. Small. 2025;21:e2406870.","journal-title":"Small"},{"key":"3675_CR42","doi-asserted-by":"crossref","unstructured":"Li YT, Tian XT, Wu ML, Zheng X, Kong QY, Cheng XX et al. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells. Int J Mol Sci. 2018;19:1030.","DOI":"10.3390\/ijms19041030"},{"key":"3675_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7150\/ntno.53844","volume":"5","author":"L Xiong","year":"2021","unstructured":"Xiong L, Lin XM, Nie JH, Ye HS, Liu J. Resveratrol and its Nanoparticle suppress Doxorubicin\/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo. Nanotheranostics. 2021;5:143\u201354.","journal-title":"Nanotheranostics"},{"key":"3675_CR44","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/OTT.S294725","volume":"14","author":"S Wen","year":"2021","unstructured":"Wen S, Qu N, Ma B, Wang X, Luo Y, Xu W, et al. Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer. Oncotargets Ther. 2021;14:1205\u201317.","journal-title":"Oncotargets Ther"},{"key":"3675_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41420-021-00524-x","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu Y, Hua F, Zhan Y, Yang Y, Xie J, Cheng Y, et al. Carcinoma associated fibroblasts small extracellular vesicles with low miR-7641 promotes breast cancer stemness and glycolysis by HIF-1\u03b1. Cell Death Discov. 2021;7:176.","journal-title":"Cell Death Discov"},{"key":"3675_CR46","doi-asserted-by":"crossref","unstructured":"Nihashi Y, Song X, Yamamoto M, Setoyama D, Kida YS. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment. Int J Mol Sci. 2023;24:11015.","DOI":"10.3390\/ijms241311015"},{"key":"3675_CR47","doi-asserted-by":"publisher","first-page":"759376","DOI":"10.3389\/fonc.2021.759376","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang J, Xu J, Liu S. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment. Front Oncol. 2021;11:759376.","journal-title":"Front Oncol"},{"key":"3675_CR48","doi-asserted-by":"publisher","first-page":"e7217","DOI":"10.1002\/cam4.7217","volume":"13","author":"S You","year":"2024","unstructured":"You S, Han X, Xu Y, Sui L, Song K, Yao Q. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK\/ERK pathway and EMT. Cancer Med-Us. 2024;13:e7217.","journal-title":"Cancer Med-Us"},{"key":"3675_CR49","first-page":"1383408018","volume":"18","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhang W, Hu X, Wang D, Tang D. Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: From Basics to Clinic. Clin Med Insights-On. 2024;18:1383408018.","journal-title":"Clin Med Insights-On"},{"key":"3675_CR50","doi-asserted-by":"crossref","unstructured":"Liang L, Li W, Li X, Jin X, Liao Q, Li Y et al. \u2018Reverse Warburg effect\u2019 of cancer\u2013associated fibroblasts (Review). Int J Oncol. 2022;60:67.","DOI":"10.3892\/ijo.2022.5357"},{"key":"3675_CR51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.7150\/jca.84601","volume":"14","author":"W Fan","year":"2023","unstructured":"Fan W, Xiong R, Zhou Z, Zhang C, Han Y, Shi T, et al. ZFP57 promotes ovarian cancer progression by transcriptionally regulating BRCA1 and managing G1 checkpoint. J Cancer. 2023;14:2039\u201350.","journal-title":"J Cancer"},{"key":"3675_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jss.2018.11.014","volume":"237","author":"Y Shoji","year":"2019","unstructured":"Shoji Y, Takamura H, Ninomiya I, Fushida S, Tada Y, Yokota T, et al. The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer. J Surg Res. 2019;237:22\u20139.","journal-title":"J Surg Res"},{"key":"3675_CR53","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.gendis.2022.03.013","volume":"10","author":"A Olechnowicz","year":"2023","unstructured":"Olechnowicz A, Oleksiewicz U, Machnik M. KRAB-ZFPs and cancer stem cells identity. Genes Dis. 2023;10:1820\u201332.","journal-title":"Genes Dis"},{"key":"3675_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, et al. Lactate Metabolism in Human Lung Tumors. Cell. 2017;171:358\u201371.","journal-title":"Cell"},{"key":"3675_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, et al. Glucose feeds the TCA cycle via circulating lactate. Nature. 2017;551:115\u20138.","journal-title":"Nature"},{"key":"3675_CR56","doi-asserted-by":"publisher","first-page":"846723","DOI":"10.3389\/fcell.2022.846723","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Chen YG. The Interplay Between TGF-\u03b2 Signaling and Cell Metabolism. Front Cell Dev Biol. 2022;10:846723.","journal-title":"Front Cell Dev Biol"},{"key":"3675_CR57","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito L, Comito G, Parri M, Iozzo M, Duatti A, Virgilio F, et al. Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer. Cancer Res. 2022;82:1267\u201382.","journal-title":"Cancer Res"},{"key":"3675_CR58","doi-asserted-by":"publisher","first-page":"113470","DOI":"10.1016\/j.intimp.2024.113470","volume":"143","author":"X Wang","year":"2024","unstructured":"Wang X, Qu Y, Ji J, Liu H, Luo H, Li J, et al. Colorectal cancer cells establish metabolic reprogramming with cancer-associated fibroblasts (CAFs) through lactate shuttle to enhance invasion, migration, and angiogenesis. Int Immunopharmacol. 2024;143:113470.","journal-title":"Int Immunopharmacol"},{"key":"3675_CR59","doi-asserted-by":"publisher","first-page":"107701","DOI":"10.1016\/j.celrep.2020.107701","volume":"31","author":"LM Becker","year":"2020","unstructured":"Becker LM, O\u2019Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, et al. Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer. Cell Rep. 2020;31:107701.","journal-title":"Cell Rep"},{"key":"3675_CR60","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn BC. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics. 2021;11:6251\u201377.","journal-title":"Theranostics"},{"key":"3675_CR61","doi-asserted-by":"publisher","first-page":"1113739","DOI":"10.3389\/fnut.2023.1113739","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Q, Huang X, Yang M, Zhou S, Li Z, et al. Lactate in the tumor microenvironment: A rising star for targeted tumor therapy. Front Nutr. 2023;10:1113739.","journal-title":"Front Nutr"},{"key":"3675_CR62","first-page":"3930","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, V\u00e9gran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118:3930\u201342.","journal-title":"J Clin Invest"},{"key":"3675_CR63","doi-asserted-by":"crossref","unstructured":"Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP et al. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci. 2017;18:2589.","DOI":"10.3390\/ijms18122589"},{"key":"3675_CR64","doi-asserted-by":"publisher","first-page":"718578","DOI":"10.3389\/fonc.2021.718578","volume":"11","author":"F Feng","year":"2021","unstructured":"Feng F, Han H, Wu S, Wang H. Crosstalk Between Abnormal TSHR Signaling Activation and PTEN\/PI3K in the Dedifferentiation of Thyroid Cancer Cells. Front Oncol. 2021;11:718578.","journal-title":"Front Oncol"},{"key":"3675_CR65","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1158\/1535-7163.MCT-12-0841","volume":"12","author":"XM Yu","year":"2013","unstructured":"Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther. 2013;12:1276\u201387.","journal-title":"Mol Cancer Ther"},{"key":"3675_CR66","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fendo.2017.00312","volume":"8","author":"D Tumino","year":"2017","unstructured":"Tumino D, Frasca F, Newbold K. Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer. Front Endocrinol. 2017;8:312.","journal-title":"Front Endocrinol"},{"issue":"Suppl 1","key":"3675_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cam4.5127","volume":"11","author":"P Jimenez-Fonseca","year":"2022","unstructured":"Jimenez-Fonseca P. Use of multikinase inhibitors\/lenvatinib in patients with high cardiovascular risk\/vasculopathy and radioiodine refractory-differentiated thyroid cancer. Cancer Med-Us. 2022;11(Suppl 1):17\u201325.","journal-title":"Cancer Med-Us"},{"key":"3675_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/a-1023-4214","volume":"52","author":"M Tsoli","year":"2020","unstructured":"Tsoli M, Alexandraki KI, Spei ME, Kaltsas GA, Daskalakis K. Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and\/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Horm Metab Res. 2020;52:25\u201331.","journal-title":"Horm Metab Res"},{"key":"3675_CR69","doi-asserted-by":"crossref","unstructured":"Song B, Wang W, Tang X, Goh R, Thuya WL, Ho P et al. Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy. Cancers. 2023;15:2758.","DOI":"10.3390\/cancers15102758"},{"key":"3675_CR70","doi-asserted-by":"publisher","first-page":"e3027","DOI":"10.1210\/clinem\/dgab196","volume":"106","author":"YS Lin","year":"2021","unstructured":"Lin YS, Zhang X, Wang C, Liu YQ, Guan WM, Liang J. Long-Term Results of a Phase II Trial of Apatinib for Progressive Radioiodine Refractory Differentiated Thyroid Cancer. J Clin Endocr Metab. 2021;106:e3027\u201336.","journal-title":"J Clin Endocr Metab"},{"key":"3675_CR71","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/curroncol31070286","volume":"31","author":"F Volpe","year":"2024","unstructured":"Volpe F, Nappi C, Zampella E, Di Donna E, Maurea S, Cuocolo A, et al. Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Curr Oncol. 2024;31:3870\u201384.","journal-title":"Curr Oncol"},{"key":"3675_CR72","doi-asserted-by":"publisher","first-page":"1408651","DOI":"10.3389\/fnut.2024.1408651","volume":"11","author":"X Yu","year":"2024","unstructured":"Yu X, Jia Y, Ren F. Multidimensional biological activities of resveratrol and its prospects and challenges in the health field. Front Nutr. 2024;11:1408651.","journal-title":"Front Nutr"},{"key":"3675_CR73","doi-asserted-by":"publisher","first-page":"1287505","DOI":"10.3389\/fphar.2023.1287505","volume":"14","author":"S Cotino-N\u00e1jera","year":"2023","unstructured":"Cotino-N\u00e1jera S, Herrera LA, Dom\u00ednguez-G\u00f3mez G, D\u00edaz-Ch\u00e1vez J. Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer. Front Pharmacol. 2023;14:1287505.","journal-title":"Front Pharmacol"},{"key":"3675_CR74","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1021\/jf505694e","volume":"63","author":"R Penalva","year":"2015","unstructured":"Penalva R, Esparza I, Larraneta E, Gonz\u00e1lez-Navarro CJ, Gamazo C, Irache JM. Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock. J Agr Food Chem. 2015;63:5603\u201311.","journal-title":"J Agr Food Chem"},{"key":"3675_CR75","doi-asserted-by":"publisher","first-page":"108461","DOI":"10.1016\/j.abb.2020.108461","volume":"689","author":"P Bian","year":"2020","unstructured":"Bian P, Hu W, Liu C, Li L. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K\/AKT\/mTOR pathway involved. Arch Biochem Biophys. 2020;689:108461.","journal-title":"Arch Biochem Biophys"},{"key":"3675_CR76","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ajpath.2016.02.003","volume":"186","author":"H Hardin","year":"2016","unstructured":"Hardin H, Yu XM, Harrison AD, Larrain C, Zhang R, Chen J, et al. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid. Am J Pathol. 2016;186:1662\u201373.","journal-title":"Am J Pathol"},{"key":"3675_CR77","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/1878-0261.13146","volume":"16","author":"JL Gulley","year":"2022","unstructured":"Gulley JL, Schlom J, Barcellos-Hoff MH, Wang XJ, Seoane J, Audhuy F, et al. Dual inhibition of TGF-\u03b2 and PD-L1: a novel approach to cancer treatment. Mol Oncol. 2022;16:2117\u201334.","journal-title":"Mol Oncol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03675-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:59:07Z","timestamp":1781636347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03675-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3675"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03675-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7685041\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Care and Use Ethics Committee of China Medical University (Approval Number: [KT20250536]) and performed in accordance with the approved protocol. The maximal tumor burden permitted was 2000\u00a0mm\u00b3, and we confirm that this limit was never exceeded. The Creation of Mechanism Diagrams by Figdraw (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of manuscript in Journal of Experimental & Clinical Cancer Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}